REFERENCES
- Kassam , F , Enright , K , Dent , R , Dranitsaris , G Myers , J . 2009 . Clemons: Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design . Clin Breast Cancer , 9 : 29 – 33 .
- Dent , R , Trudeau , M , Pritchard , K I , Hanna , W M Kahn , H K . 2007 . Triple-negative breast cancer: clinical features and patterns of recurrence . Clin Cancer Res , 13 : 4429 – 4434 .
- Mantovani , A , Allavena , P , Sica , A and Balkwill , F . 2008 . Cancer-related inflammation . Nature , 454 : 436 – 444 .
- Morin , K H , Stark , M A and Searing , K . 2004 . Obesity and nutrition in women throughout adulthood . J Obstet Gynecol Neonatal Nurs , 33 : 823 – 832 .
- Pierobon , M and Frankenfeld , C L . 2013 . Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis . Breast Cancer Res Treat , 137 : 307 – 314 .
- Ligibel , J A and Strickler , H D . 2013 . Obesity and its impact on breast cancer . Am Soc Clin Oncol Educ Book , 33 : 52 – 59 .
- Iyengar , N M , Hudis , C A and Dannenberg , A J . 2013 . Obesity and inflammation . Am Soc Clin Oncol Educ Book , 33 : 46 – 51 .
- Adams , L S , Phung , S , Yee , N , Seeram , N P Li , L . 2010 . Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway . Cancer Res , 70 : 3594 – 3605 .
- Adams , L S , Kanaya , N , Phung , S , Liu , Z and Chen , S . 2011 . Whole blueberry powder modulates the growth and metastasis of MDA-MB-231 triple negative breast tumors in nude mice . J Nutr , 141 : 1805 – 1812 .
- Kajitani , K , Tanaka , Y , Arihiro , K , Kataoka , T and Ohdan , H . 2012 . Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells . Breast Cancer Res Treat , 134 : 139 – 155 .
- Brunda , M J . 1994 . Interleukin-12 . J Leukoc Biol , 55 : 280 – 288 .
- Liao , W , Lin , J X and Leonard , W J . 2013 . Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy . Immunity , 38 : 13 – 25 .
- Chu , W M . 2013 . Tumor necrosis factor . Cancer Lett , 328 : 222 – 225 .
- Steding , C E , Wu , S T , Zhang , Y , Jeng , M H Elzey , B D . 2011 . The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis . Immunology , 133 : 221 – 238 .
- Suzuki , R , Namai , E , Oda , Y , Nishiie , N Otake , S . 2010 . Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure . J Control Release , 142 : 245 – 250 .
- Reagan-Shaw , S , Nihal , M and Ahmad , N . 2008 . Dose translation from animal to human studies revisited . FASEB J , 22 : 659 – 661 .